TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Other Assets, Noncurrent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Teva Pharmaceutical Industries Ltd quarterly Other Assets, Noncurrent history and growth rate from 2010 to 2024.
  • Teva Pharmaceutical Industries Ltd Other Assets, Noncurrent for the quarter ending March 31, 2024 was $470 M, a 4.44% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $470 M +$20 M +4.44% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $470 M +$29 M +6.58% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $477 M +$39 M +8.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $443 M -$11 M -2.42% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $450 M -$22 M -4.66% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $441 M -$74 M -14.4% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $438 M -$80 M -15.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $454 M -$76 M -14.3% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $472 M -$52 M -9.92% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $515 M -$23 M -4.28% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $518 M -$304 M -37% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $530 M -$30 M -5.36% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $524 M -$26 M -4.73% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $538 M -$53 M -8.97% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $822 M +$95 M +13.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $560 M -$161 M -22.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $550 M -$206 M -27.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $591 M -$140 M -19.2% Dec 31, 2019 10-K 2021-02-10
Q3 2019 $727 M +$5 M +0.69% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $721 M -$85 M -10.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $756 M -$76 M -9.14% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $731 M -$201 M -21.6% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $722 M -$327 M -31.2% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $806 M -$439 M -35.3% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $832 M -$487 M -36.9% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $932 M -$303 M -24.5% Dec 31, 2017 10-K 2019-02-19
Q3 2017 $1.05 B -$1.02 B -49.2% Sep 30, 2017 6-K 2017-11-02
Q2 2017 $1.25 B -$1.39 B -52.8% Jun 30, 2017 6-K 2017-08-03
Q1 2017 $1.32 B -$1.34 B -50.4% Mar 31, 2017 6-K 2017-05-11
Q4 2016 $1.24 B -$1.11 B -47.2% Dec 31, 2016 10-K 2018-02-12
Q3 2016 $2.06 B -$405 M -16.4% Sep 30, 2016 6-K 2016-11-15
Q2 2016 $2.64 B -$534 M -16.8% Jun 30, 2016 6-K 2016-08-04
Q1 2016 $2.66 B +$949 M +55.4% Mar 31, 2016 6-K 2016-05-09
Q4 2015 $2.34 B +$772 M +49.2% Dec 31, 2015 20-F 2017-02-15
Q3 2015 $2.47 B +$990 M +66.9% Sep 30, 2015 6-K 2015-10-29
Q2 2015 $3.17 B +$1.7 B +116% Jun 30, 2015 6-K 2015-07-30
Q1 2015 $1.71 B +$242 M +16.5% Mar 31, 2015 6-K 2015-04-30
Q4 2014 $1.57 B -$127 M -7.49% Dec 31, 2014 20-F 2016-02-11
Q3 2014 $1.48 B -$53 M -3.46% Sep 30, 2014 6-K 2014-10-30
Q2 2014 $1.47 B +$70 M +5% Jun 30, 2014 6-K 2014-07-31
Q1 2014 $1.47 B +$85 M +6.14% Mar 31, 2014 6-K 2014-05-02
Q4 2013 $1.7 B +$358 M +26.8% Dec 31, 2013 20-F 2015-02-09
Q3 2013 $1.53 B +$1.38 B +935% Sep 30, 2013 6-K 2013-10-31
Q2 2013 $1.4 B +$1.29 B +1149% Jun 30, 2013 6-K 2013-08-01
Q1 2013 $1.39 B +$1.22 B +750% Mar 31, 2013 6-K 2013-05-02
Q4 2012 $1.34 B +$205 M +18.1% Dec 31, 2012 20-F 2014-02-10
Q3 2012 $148 M +$72 M +94.7% Sep 30, 2012 6-K 2012-11-01
Q2 2012 $112 M +$24 M +27.3% Jun 30, 2012 6-K 2012-08-02
Q1 2012 $163 M +$136 M +504% Mar 31, 2012 6-K 2012-05-09
Q4 2011 $1.13 B +$995 M +721% Dec 31, 2011 20-F 2013-02-12
Q3 2011 $76 M -$743 M -90.7% Sep 30, 2011 6-K 2011-11-02
Q2 2011 $88 M -$542 M -86% Jun 30, 2011 6-K 2011-07-28
Q1 2011 $27 M -$576 M -95.5% Mar 31, 2011 6-K 2011-05-11
Q4 2010 $138 M Dec 31, 2010 20-F 2012-02-17
Q3 2010 $819 M Sep 30, 2010 6-K 2010-11-02
Q2 2010 $630 M Jun 30, 2010 6-K 2010-07-27
Q1 2010 $603 M Mar 31, 2010 6-K 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.